Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$731,292,700
-$281,003,226 QoQ
Shares Held
1,172,808
-10.6% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#16
of 1,297 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. REGN ranks #2 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $731,292,700 | 1,172,808 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $1,012,295,926 | 1,311,485 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $628,151,475 | 1,196,479 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $715,743,776 | 1,128,524 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $802,035,853 | 1,125,933 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,179,602,711 | 1,122,106 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $1,184,456,156 | 1,126,948 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,062,852,682 | 1,104,274 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $932,570,956 | 1,061,803 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $871,310,545 | 1,058,752 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $751,847,921 | 1,046,355 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $822,584,518 | 1,001,113 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $697,296,275 | 966,467 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $624,538,497 | 906,613 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $521,559,910 | 882,310 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $689,784,735 | 987,636 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $609,221,660 | 964,691 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $593,309,999 | 980,386 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $579,042,327 | 1,036,707 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $463,870,241 | 980,408 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $506,838,913 | 1,049,117 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $656,117,578 | 1,172,099 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $781,762,113 | 1,253,527 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $400,522,313 | 820,255 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||